TETeva TEVA · NYSE
$42.08 +1.48% (+$0.62)
- Market cap
- $48.3B
- Enterprise value
- $61.5B
- P/E
- 68.4x
- Forward P/E
- 20.1x
- PEG
- -
- P/S
- 2.8x
- P/FCF
- 35.8x
- EV/EBITDA
- 23.7x
- ROIC
- 6.8%
- Gross margin
- 52.5%
- Net margin
- 4.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 5.1x
- Beta
- 0.82
- Free float
- 95.1%
About the company
Teva Pharmaceutical Industries (TEVA) is an Israeli pharmaceutical company specializing in the development, production, and distribution of generic drugs and specialty pharmaceutical products. With a broad portfolio of generic medicines and proprietary products in areas such as neurology, oncology, and respiratory diseases, Teva is one of the largest producers of generic drugs in the world. The company is known for its ability to provide affordable medications and innovative treatment options for patients worldwide. Teva also invests in the research and development of new pharmaceuticals and biologics. Teva Pharmaceutical Industries (TEVA) shares could be suitable for investors looking for opportunities in the pharmaceutical sector with a focus on generic drugs and specialty treatments.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Employees
32,008
Headquarters
Tel Aviv
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: It beat profit estimates 7 times in the last 8 quarters.
- What to watch: Analysts expect revenue to fall by 5.3% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: Out of every 100 USD of revenue, only 4.1 USD is left as net profit.
Financial health
Can it carry its debt?
- What to watch: Repaying its net debt would take 5.1 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number